Clinical Trial Update: ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study [Phase 3]

View source ↗

Summary

This clinical trial update reports on the Phase 3 open-label extension study of ACP-204 for adults with Alzheimer's disease with psychosis, focusing on enrollme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ACP-204

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Alzheimer's Disease Psychosis | Phase 3 | Status: ENROLLING_BY_INVITATION